Stock Events

Stock Events

Awakn Life Sciences 

$0.07
11
-$0.01-7.14% Monday 20:00

Statistics

Day High
0.08
Day Low
0.07
52W High
0.13
52W Low
0.05
Volume
8,231
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Apr 22
$4.35
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

24AprExpected
Q1 2022
Q2 2022
Q3 2022
Q1 2024
Q2 2024
Q3 2024
Q1 2025
-0.17
-0.13
-0.08
-0.04
Expected EPS
N/A
Actual EPS
N/A

Financials

-491.51%Profit Margin
Unprofitable
2021
2022
2023
771,881.33Revenue
-3.79MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AWKNF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap606.35M
Compass Pathways focuses on psilocybin therapy for mental health disorders, directly competing in the psychedelic-assisted therapy market.
AtaiBeckley
ATAI
Mkt Cap1.56B
ATAI Life Sciences works on biotech and psychedelic treatments for mental health disorders, overlapping with Awakn's therapeutic approaches.
GH Research
GHRS
Mkt Cap888.26M
GH Research is involved in developing 5-MeO-DMT therapies for depression, competing in the psychedelic treatment space.
Cybin Inc
CYBN
Mkt Cap200.49M
Cybin Inc. develops psychedelic compounds for therapy, similar to Awakn's work with ketamine and other related substances.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness focuses on psychedelic production and therapy, targeting the same innovative mental health treatments as Awakn.
Revive Therapeutics
RVVTF
Mkt Cap4.68M
Revive Therapeutics explores psilocybin-based treatments, positioning itself in the same emerging sector as Awakn.
Noveris Health Sciences
MYCOF
Mkt Cap14.59M
Mydecine Innovations Group works on developing and deploying psychedelic medicine, competing in the same niche as Awakn.

About

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Toronto, Canada.
Show more...
CEO
Mr. George Scorsis
Employees
6
Country
US

Listings

0 Comments

Share your thoughts

FAQ

What is Awakn Life Sciences stock price today?▼
The current price of AWKNF is $0.07 USD — it has decreased by -7.14% in the past 24 hours. Watch Awakn Life Sciences stock price performance more closely on the chart.
What is Awakn Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Awakn Life Sciences stocks are traded under the ticker AWKNF.
What is Awakn Life Sciences revenue for the last year?▼
Awakn Life Sciences revenue for the last year amounts to 771,881.33 USD.
What is Awakn Life Sciences net income for the last year?▼
AWKNF net income for the last year is -3.79M USD.
Does Awakn Life Sciences pay dividends?▼
Yes, AWKNF dividends are paid annual. The last dividend per share was 4.35 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Awakn Life Sciences have?▼
As of April 02, 2026, the company has 6 employees.
In which sector is Awakn Life Sciences located?▼
Awakn Life Sciences operates in the Health Care sector.
When did Awakn Life Sciences complete a stock split?▼
Awakn Life Sciences has not had any recent stock splits.
Where is Awakn Life Sciences headquartered?▼
Awakn Life Sciences is headquartered in Toronto, US.